RCEL Oct 2024 17.500 call
| Previous close | 0.5000 |
| Open | 0.7500 |
| Bid | 0.0000 |
| Ask | 0.7500 |
| Strike | 17.50 |
| Expiry date | 2024-10-18 |
| Day's range | 0.5000 - 0.7500 |
| Contract range | N/A |
| Volume | |
| Open interest | 80 |
GlobeNewswireAVITA Medical Announces FDA Approval of RECELL GO
VALENCIA, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that the U.S. Food and Drug Administration (FDA) has approved its premarket approval (PMA) supplement for the RECELL GO™ System, its next-generation autologous cell harvesting device that harnesses the regenerative properties of a patient’s own skin to tre
GlobeNewswireAVITA Medical to Host Investor Webinar Briefing
VALENCIA, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, invites shareholders and prospective investors to attend its investor webinar briefing and presentation by Jim Corbett, Chief Executive Officer, and David O’Toole, Chief Financial Officer, on May 21, 2024, at 4:00 p.m. Pacific Daylight Time / May 22, 2024, at 9:00 a.m. Au
- GuruFocus.com
AVITA Medical Inc (AVHHL) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges ...
Despite a challenging quarter, AVITA Medical Inc (AVHHL) reaffirms full-year revenue guidance and progresses on strategic initiatives.
